Impact of chromium dinicocysteinate supplementation on inflammation, oxidative stress, and insulin resistance in type 2 diabetic subjects: an exploratory analysis of a randomized, double-blind, placebo-controlled study

BACKGROUND: Chromium dinicocysteinate (CDNC) is a unique chromium complex consisting of chromium, niacin, and L-cysteine. Previous preclinical and clinical studies support the safety and efficacy of CDNC in modulating oxidative stress, vascular inflammation, and glycemia in type 2 diabetes. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiyed, Zainulabedin M., Lugo, James P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043078/
https://www.ncbi.nlm.nih.gov/pubmed/27687012
http://dx.doi.org/10.3402/fnr.v60.31762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043078/
https://www.ncbi.nlm.nih.gov/pubmed/27687012
http://dx.doi.org/10.3402/fnr.v60.31762

Ejemplares similares